{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:28:12Z","timestamp":1791919692171,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry &amp; Cell Biology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.biocel.2024.106554","type":"journal-article","created":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T19:05:45Z","timestamp":1708801545000},"page":"106554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["PLA inhibits TNF-\u03b1-induced PANoptosis of prostate cancer cells through metabolic reprogramming"],"prefix":"10.1016","volume":"169","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5030-7446","authenticated-orcid":false,"given":"Yinghui","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangmei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenqiong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeping","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4841-5179","authenticated-orcid":false,"given":"Jinhua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biocel.2024.106554_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032939","article-title":"Mechanisms of Prostate Cancer Cells Survival and Their Therapeutic Targeting [J]","volume":"24","author":"Pej\u010di\u0107","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biocel.2024.106554_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061973","article-title":"Tumor Immune Microenvironment Clusters in Localized Prostate Adenocarcinoma: Prognostic Impact of Macrophage Enriched\/Plasma Cell Non-Enriched Subtypes [J]","volume":"9","author":"Jairath","year":"2020","journal-title":"J. Clin. Med."},{"issue":"36","key":"10.1016\/j.biocel.2024.106554_bib3","article-title":"Increased expression of miR-153 predicts poor prognosis for patients with prostate cancer [J]","volume":"98","author":"Bi","year":"2019","journal-title":"Med. (Baltim. )"},{"issue":"12","key":"10.1016\/j.biocel.2024.106554_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121995","article-title":"Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-\u03b2 Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer [J]","volume":"11","author":"Sharad","year":"2019","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.biocel.2024.106554_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12010-014-0955-6","article-title":"Metabolomics approaches and applications in prostate cancer research [J]","volume":"174","author":"Zhang","year":"2014","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"8","key":"10.1016\/j.biocel.2024.106554_bib6","article-title":"An Update on the Prognostic and Predictive Serum Biomarkers in Metastatic Prostate Cancer [J]","volume":"10","author":"Saxby","year":"2020","journal-title":"Diagn. (Basel)"},{"issue":"16","key":"10.1016\/j.biocel.2024.106554_bib7","first-page":"3284","article-title":"High-throughput metabolomics to identify metabolites to serve as diagnostic biomarkers of prostate cancer [J]","volume":"8","author":"Li","year":"2016"},{"key":"10.1016\/j.biocel.2024.106554_bib8","article-title":"Serum organic acid metabolites can be used as potential biomarkers to identify prostatitis, benign prostatic hyperplasia, and prostate cancer [J]","volume":"13","author":"He","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.biocel.2024.106554_bib9","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00253-012-4269-8","article-title":"Recent research on 3-phenyllactic acid, a broad-spectrum antimicrobial compound [J]","volume":"95","author":"Mu","year":"2012","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.biocel.2024.106554_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104239","article-title":"Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios [J]","volume":"68","author":"Oezguen","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"12","key":"10.1016\/j.biocel.2024.106554_bib11","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1039\/D1FO00166C","article-title":"Phenyl lactic acid alleviates Samonella Typhimurium-induced colitis via regulating microbiota composition, SCFA production and inflammatory responses [J]","volume":"12","author":"Zhou","year":"2021","journal-title":"Food Funct."},{"issue":"6","key":"10.1016\/j.biocel.2024.106554_bib12","first-page":"11384","article-title":"Increasing aggressive prostate cancer [J]","volume":"29","author":"Shah","year":"2022","journal-title":"Can. J. Urol."},{"issue":"7","key":"10.1016\/j.biocel.2024.106554_bib13","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/BF02136914","article-title":"Phenylacetic acid as a potential therapeutic agent for the treatment of human cancer [J]","volume":"27","author":"Neish","year":"1971","journal-title":"Experientia"},{"key":"10.1016\/j.biocel.2024.106554_bib14","article-title":"A new anti-colon cancer tumor pathway of Phenyllactic acid by reducing adhesion of Fusobacterium nucleatum [J]","volume":"43","author":"Wu","year":"2023"},{"key":"10.1016\/j.biocel.2024.106554_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12935-019-0965-0","article-title":"Phenyllactic acid promotes cell migration and invasion in cervical cancer via IKK\/NF-\u03baB-mediated MMP-9 activation [J]","volume":"19","author":"Li","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"9","key":"10.1016\/j.biocel.2024.106554_bib16","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1021\/pr200310s","article-title":"UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model [J]","volume":"10","author":"Manna","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.biocel.2024.106554_bib17","article-title":"\"More men die with prostate cancer than because of it\" - an old adage that still holds true in the 21st century [J]","volume":"26","author":"C","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.biocel.2024.106554_bib18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mib.2020.07.012","article-title":"PANoptosis in microbial infection [J]","volume":"59","author":"Place","year":"2021","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.biocel.2024.106554_bib19","article-title":"Advances in mechanism and regulation of PANoptosis: Prospects in disease treatment [J]","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biocel.2024.106554_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fcimb.2020.00237","article-title":"Identification of the PANoptosome: A Molecular Platform Triggering Pyroptosis, Apoptosis, and Necroptosis (PANoptosis) [J]","volume":"10","author":"Christgen","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.biocel.2024.106554_bib21","article-title":"RIPK1 in the inflammatory response and sepsis: Recent advances, drug discovery and beyond [J]","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biocel.2024.106554_bib22","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1016\/j.csbj.2021.07.038","article-title":"From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways [J]","volume":"19","author":"Wang","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.biocel.2024.106554_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109019","article-title":"Characterization of PANoptosis patterns predicts survival and immunotherapy response in gastric cancer [J]","volume":"238","author":"Pan","year":"2022","journal-title":"Clin. Immunol. (Orlando, Fla)"},{"key":"10.1016\/j.biocel.2024.106554_bib24","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.2147\/JIR.S403819","article-title":"PANoptosis: A Cell Death Characterized by Pyroptosis, Apoptosis, and Necroptosis [J]","volume":"16","author":"Shi","year":"2023","journal-title":"J. Inflamm. Res"},{"issue":"9","key":"10.1016\/j.biocel.2024.106554_bib25","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.4049\/jimmunol.2200508","article-title":"PANoptosis: A Unique Innate Immune Inflammatory Cell Death Modality [J]","volume":"209","author":"Pandian","year":"2022","journal-title":"J. Immunol. (Baltim., Md: 1950)"},{"issue":"3","key":"10.1016\/j.biocel.2024.106554_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109858","article-title":"ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis [J]","volume":"37","author":"Karki","year":"2021","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.biocel.2024.106554_bib27","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s12967-022-03641-y","article-title":"CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial-mesenchymal transition, G2\/M phase transition, and PANoptosis [J]","volume":"20","author":"Ren","year":"2022","journal-title":"J. Transl. Med"},{"issue":"1","key":"10.1016\/j.biocel.2024.106554_bib28","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s12885-020-06827-z","article-title":"Tumor characteristics, treatments, and survival outcomes in prostate cancer patients with a PSA level\u2009<\u20094\u2009ng\/ml: a population-based study [J]","volume":"20","author":"Zheng","year":"2020","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.biocel.2024.106554_bib29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.immuni.2015.09.001","article-title":"Metabolic Reprogramming of Immune Cells in Cancer Progression [J]","volume":"43","author":"Biswas","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.biocel.2024.106554_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijfoodmicro.2022.109606","article-title":"Energy metabolism as the target of 3-phenyllactic acid against Rhizopus oryzae [J]","volume":"369","author":"Fan","year":"2022","journal-title":"Int. J. Food Microbiol."},{"issue":"12","key":"10.1016\/j.biocel.2024.106554_bib31","doi-asserted-by":"crossref","first-page":"9463","DOI":"10.3168\/jds.2022-22262","article-title":"Antibacterial activity and action target of phenyllactic acid against Staphylococcus aureus and its application in skim milk and cheese [J]","volume":"105","author":"Jiang","year":"2022","journal-title":"J. Dairy Sci."},{"issue":"7","key":"10.1016\/j.biocel.2024.106554_bib32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/mc.23413","article-title":"Characterization of stage-specific tumor progression in TMPRSS2-ERG (fusion)-driven and non-fusion-driven prostate cancer in GEM models [J]","volume":"61","author":"Raina","year":"2022","journal-title":"Mol. Carcinog."},{"issue":"2","key":"10.1016\/j.biocel.2024.106554_bib33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent [J]","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.biocel.2024.106554_bib34","first-page":"5","article-title":"Prostate cancer between prognosis and adequate\/proper therapy [J]","volume":"10","author":"Grozescu","year":"2017","journal-title":"J. Med. life"},{"issue":"4","key":"10.1016\/j.biocel.2024.106554_bib35","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.emc.2021.07.005","article-title":"Abdominal Pain in the Emergency Department: Missed Diagnoses [J]","volume":"39","author":"Halsey-Nichols","year":"2021","journal-title":"Emerg. Med. Clin. North Am."},{"issue":"1","key":"10.1016\/j.biocel.2024.106554_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ucl.2020.09.010","article-title":"Recent Advances and Current Role of Transperineal Prostate Biopsy [J]","volume":"48","author":"Bhanji","year":"2021","journal-title":"Urol. Clin. North Am."},{"issue":"10","key":"10.1016\/j.biocel.2024.106554_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11101449","article-title":"Increased Plasmatic Levels of PSA-Expressing Exosomes Distinguish Prostate Cancer Patients from Benign Prostatic Hyperplasia: A Prospective Study [J]","volume":"11","author":"Logozzi","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.biocel.2024.106554_bib38","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.clnesp.2021.04.002","article-title":"Effect of an intensified individual nutrition therapy on serum metabolites in critically ill patients - A targeted metabolomics analysis of the ONCA study [J]","volume":"43","author":"Gonzalez-Granda","year":"2021","journal-title":"Clin. Nutr. ESPEN"},{"issue":"2","key":"10.1016\/j.biocel.2024.106554_bib39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/1871520616666161031143301","article-title":"The Warburg Effect and the Hallmarks of Cancer [J]","volume":"17","author":"Schwartz","year":"2017","journal-title":"Anti-Cancer Agents Med. Chem."},{"issue":"6","key":"10.1016\/j.biocel.2024.106554_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188988","article-title":"The Warburg effect on radioresistance: Survival beyond growth [J]","volume":"1878","author":"Kang","year":"2023","journal-title":"Biochim. Et. Biophys. Acta Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biocel.2024.106554_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11010028","article-title":"Metabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis [J]","volume":"11","author":"Ohshima","year":"2021","journal-title":"Metabolites"},{"issue":"4","key":"10.1016\/j.biocel.2024.106554_bib42","article-title":"Effect of Steroid Hormones, Prostaglandins (E2 and F2\u03b1), Oxytocin, and Tumor Necrosis Factor Alpha on Membrane Progesterone (P4) Receptors Gene Expression in Bovine Myometrial Cells [J]","volume":"12","author":"Kowalik","year":"2022","journal-title":"Anim.: Open Access J. MDPI"},{"issue":"1","key":"10.1016\/j.biocel.2024.106554_bib43","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41392-022-00889-0","article-title":"Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis [J]","volume":"7","author":"Lin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.biocel.2024.106554_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/biom11020247","article-title":"Post-Translational Modifications That Drive Prostate Cancer Progression [J]","volume":"11","author":"Samar\u017eija","year":"2021","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.biocel.2024.106554_bib45","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.molcel.2018.07.027","article-title":"SUMO-Mediated Regulation of Nuclear Functions and Signaling Processes [J]","volume":"71","author":"Zhao","year":"2018","journal-title":"Mol. Cell"},{"issue":"24","key":"10.1016\/j.biocel.2024.106554_bib46","article-title":"In Vitro Phytochemical Screening, Cytotoxicity Studies of Curcuma longa Extracts with Isolation and Characterisation of Their Isolated Compounds [J]","volume":"26","author":"Grover","year":"2021","journal-title":"Mol. (Basel, Switz. )"},{"issue":"24","key":"10.1016\/j.biocel.2024.106554_bib47","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.2174\/0929867328666201228124038","article-title":"Resveratrol and Prostate Cancer: The Power of Phytochemicals [J]","volume":"28","author":"Zaffaroni","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"11","key":"10.1016\/j.biocel.2024.106554_bib48","doi-asserted-by":"crossref","first-page":"9307","DOI":"10.1007\/s11033-023-08828-0","article-title":"The synergistic effects of betanin and radiotherapy in a prostate cancer cell line: an in vitro study [J]","volume":"50","author":"Montazersaheb","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.biocel.2024.106554_bib49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mnfr.201400484","article-title":"Betanin--a food colorant with biological activity [J]","volume":"59","author":"Esatbeyoglu","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"issue":"4","key":"10.1016\/j.biocel.2024.106554_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042214","article-title":"Specific Gut Microbial Environment in Lard Diet-Induced Prostate Cancer Development and Progression [J]","volume":"23","author":"Sato","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.biocel.2024.106554_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/nu12092648","article-title":"The Crosstalk between Prostate Cancer and Microbiota Inflammation: Nutraceutical Products Are Useful to Balance This Interplay? [J]","volume":"12","author":"Crocetto","year":"2020","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.biocel.2024.106554_bib52","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/iju.14894","article-title":"Gut microbiome and prostate cancer [J]","volume":"29","author":"Fujita","year":"2022","journal-title":"Int. J. Urol.: Off. J. Jpn. Urol. Assoc."},{"issue":"3","key":"10.1016\/j.biocel.2024.106554_bib53","doi-asserted-by":"crossref","first-page":"236","DOI":"10.7150\/ntno.77564","article-title":"Natural and synthetic nanovectors for cancer therapy [J]","volume":"7","author":"Eftekhari","year":"2023","journal-title":"Nanotheranostics"},{"key":"10.1016\/j.biocel.2024.106554_bib54","article-title":"Stimuli-responsive (nano)architectures for phytochemical delivery in cancer therapy [J]","volume":"166","author":"Zandieh","year":"2023","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.biocel.2024.106554_bib55","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1080\/21691401.2016.1269117","article-title":"Liposome-mediated RNA interference delivery against Erk1 and Erk2 does not equally promote chemosensitivity in human hepatocellular carcinoma cell line HepG2 [J]","volume":"45","author":"Mehdizadeh","year":"2017","journal-title":"Artif. Cells, Nanomed., Biotechnol."},{"issue":"9","key":"10.1016\/j.biocel.2024.106554_bib56","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2174\/1568009621666210601114631","article-title":"Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks [J]","volume":"21","author":"Soleymani","year":"2021","journal-title":"Curr. Cancer Drug Targets"},{"issue":"21","key":"10.1016\/j.biocel.2024.106554_bib57","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.7150\/thno.36735","article-title":"Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-\u03b2 signaling [J]","volume":"9","author":"Dai","year":"2019","journal-title":"Theranostics"}],"container-title":["The International Journal of Biochemistry &amp; Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272524000451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272524000451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:26:18Z","timestamp":1761204378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272524000451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":57,"alternative-id":["S1357272524000451"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2024.106554","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PLA inhibits TNF-\u03b1-induced PANoptosis of prostate cancer cells through metabolic reprogramming","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2024.106554","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106554"}}